53
|
219
|
7fjsA |
Crystal structure of t6 fab bound to thesars-cov-2 rbd of b.1.351 |
18
|
107
|
7fjoF |
Cryo-em structure of south african (b.1.351) sars-cov-2 spike glycoprotein in complex with three t6 fab |
66
|
472
|
7n28A |
Cryo-em structure of broadly neutralizing v2-apex-targeting antibody j033 in complex with hiv-1 env |
42
|
195
|
7fjsB |
Crystal structure of t6 fab bound to thesars-cov-2 rbd of b.1.351 |
45
|
221
|
8gf2L |
Crystal structure of sars-cov-2 receptor binding domain in complex with antibodies ecr3022.20 and cc12.3 |
36
|
195
|
8gf2A |
Crystal structure of sars-cov-2 receptor binding domain in complex with antibodies ecr3022.20 and cc12.3 |
37
|
218
|
8gf2C |
Crystal structure of sars-cov-2 receptor binding domain in complex with antibodies ecr3022.20 and cc12.3 |
43
|
211
|
8gf2D |
Crystal structure of sars-cov-2 receptor binding domain in complex with antibodies ecr3022.20 and cc12.3 |
41
|
221
|
8gf2H |
Crystal structure of sars-cov-2 receptor binding domain in complex with antibodies ecr3022.20 and cc12.3 |
39
|
211
|
7triY |
Human antibody s8v1-172 in complex with the influenza hemagglutinin head domain of a/sydney/05/1997(h3n2) |
45
|
214
|
7trhB |
Human antibody k03.28 in complex with the influenza hemagglutinin head domain of a/california/07/2009(h1n1)(x-181) |
44
|
214
|
7trhG |
Human antibody k03.28 in complex with the influenza hemagglutinin head domain of a/california/07/2009(h1n1)(x-181) |
64
|
272
|
7triB |
Human antibody s8v1-172 in complex with the influenza hemagglutinin head domain of a/sydney/05/1997(h3n2) |
39
|
224
|
7triZ |
Human antibody s8v1-172 in complex with the influenza hemagglutinin head domain of a/sydney/05/1997(h3n2) |
42
|
227
|
7trhH |
Human antibody k03.28 in complex with the influenza hemagglutinin head domain of a/california/07/2009(h1n1)(x-181) |
9
|
107
|
7wt9A |
Sars-cov-2 omicron variant spike rbd in complex with fab 9a8 |
19
|
201
|
7wt9E |
Sars-cov-2 omicron variant spike rbd in complex with fab 9a8 |
9
|
122
|
7wt9H |
Sars-cov-2 omicron variant spike rbd in complex with fab 9a8 |
48
|
220
|
8dnnC |
Crystal structure of neutralizing antibody 80 in complex with sars-cov-2 receptor binding domain |
37
|
195
|
8dnnA |
Crystal structure of neutralizing antibody 80 in complex with sars-cov-2 receptor binding domain |
46
|
227
|
8dnnB |
Crystal structure of neutralizing antibody 80 in complex with sars-cov-2 receptor binding domain |
51
|
216
|
8faxB |
Fab 1249a8-mers stem helix complex |
49
|
221
|
8faxA |
Fab 1249a8-mers stem helix complex |
3
|
12
|
8faxL |
Fab 1249a8-mers stem helix complex |
37
|
196
|
7yowC |
Crystal structure of sars-cov-2 omicron variant spike receptor-binding domain (rbd) in complex with ncv2sg48 fab |
41
|
216
|
7yowB |
Crystal structure of sars-cov-2 omicron variant spike receptor-binding domain (rbd) in complex with ncv2sg48 fab |
40
|
215
|
7yowA |
Crystal structure of sars-cov-2 omicron variant spike receptor-binding domain (rbd) in complex with ncv2sg48 fab |
11
|
108
|
8d21F |
Cryo-em structure of the vrc321 clinical trial, vaccine-elicited, human antibody 1b06 in complex with a stabilized nc99 ha trimer |
44
|
323
|
8d21A |
Cryo-em structure of the vrc321 clinical trial, vaccine-elicited, human antibody 1b06 in complex with a stabilized nc99 ha trimer |
50
|
173
|
8d21B |
Cryo-em structure of the vrc321 clinical trial, vaccine-elicited, human antibody 1b06 in complex with a stabilized nc99 ha trimer |
18
|
123
|
8d21E |
Cryo-em structure of the vrc321 clinical trial, vaccine-elicited, human antibody 1b06 in complex with a stabilized nc99 ha trimer |
72
|
275
|
8gomA |
Sars-cov-2 specific private tcr rlq7 in complex with rlq-hla-a2 |
15
|
118
|
7wp8H |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk1628x in complex with three neutralizing antibodies |
16
|
119
|
7wp8E |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk1628x in complex with three neutralizing antibodies |
52
|
244
|
8gomE |
Sars-cov-2 specific private tcr rlq7 in complex with rlq-hla-a2 |
13
|
100
|
8gomB |
Sars-cov-2 specific private tcr rlq7 in complex with rlq-hla-a2 |
39
|
192
|
8gonD |
Sars-cov-2 specific private tcr rlq7 in complex with rlq-t1006i-hla-a2 |
76
|
275
|
8gonA |
Sars-cov-2 specific private tcr rlq7 in complex with rlq-t1006i-hla-a2 |
55
|
245
|
8gonE |
Sars-cov-2 specific private tcr rlq7 in complex with rlq-t1006i-hla-a2 |
17
|
118
|
7wp8D |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk1628x in complex with three neutralizing antibodies |
0
|
9
|
8gomC |
Sars-cov-2 specific private tcr rlq7 in complex with rlq-hla-a2 |
10
|
104
|
7wp8C |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk1628x in complex with three neutralizing antibodies |
11
|
113
|
7wp8G |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk1628x in complex with three neutralizing antibodies |
15
|
106
|
7wp8L |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk1628x in complex with three neutralizing antibodies |
35
|
193
|
8gomD |
Sars-cov-2 specific private tcr rlq7 in complex with rlq-hla-a2 |
15
|
100
|
8gonB |
Sars-cov-2 specific private tcr rlq7 in complex with rlq-t1006i-hla-a2 |
15
|
183
|
7wp8F |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk1628x in complex with three neutralizing antibodies |
12
|
113
|
7wp6I |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk in complex with three neutralizing antibodies |
15
|
118
|
7wp6H |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk in complex with three neutralizing antibodies |
16
|
119
|
7wp6B |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk in complex with three neutralizing antibodies |